COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models

por Maisonnasse, P, Aldon, Y, Marc, A, Marlin, R, Dereuddre-Bosquet, N, Kuzmina, NA, Freyn, AW, Snitselaar, JL, Gonçalves, A, Caniels, TG, Burger, JA, Poniman, M, Chesnais, V, Diry, S, Iershov, A, Ronk, AJ, Jangra, S, Rathnasinghe, R, Brouwer, PJM, Bijl, TPL, van Schooten, J, Brinkkemper, M, Liu, H, Yuan, M, Mire, CE, van Breemen, MJ, Contreras, V, Naninck, T, Lemaître, J, Kahlaoui, N, Relouzat, F, Chapon, C, Ho Tsong Fang, R, McDanal, C, Osei-Twum, M, St-Amant, N, Gagnon, L, Montefiori, DC, Wilson, IA, Ginoux, E, de Bree, GJ, García-Sastre, A, Schotsaert, M, Coughlan, L, Bukreyev, A, van der Werf, S, Guedj, J, Sanders, RW, van Gils, MJ, Le Grand, R
Publicado 2021